Principal Scientist, Regeneron, Jay Caplan, President and Founder, Fractyl Health, Jerry Colca, Chief Scientific Officer, Cirius Therapeutics, Johan Fredrik Paulsson, Director Incretin and Amylin Biology, Novo Nordisk, Mina Sooch, Founder and General Partner, Apjohn Ventures, Scott Harris, Chief Medical Officer, Altimmune, Zohar Barbash, Chief Technology Officer, Lembas Bio Saturday, Aug 01, 2026 10:00a Atlantic Wharf Thursday, Jul 30, 2026 7:30p The Comedy Studio Saturday, Aug 01, 2026 6:00p John F
Activates GLP-1 receptors in the hypothalamus, reducing appetite
The goal isnt to sell you on a shot its to help you ask your provider the right questions
Chronic kidney disease in heart failure with preserved ejection fraction In the pooled analysis of the SUSTAIN 6 and LEADER trials, with median follow-up periods of 2.1 and 3.8 years respectively, semaglutide and liraglutide demonstrated significant renal benefits compared to placebo
Retrieved 4 December 2019